From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA panel says no to over-the-counter allergy drug Singulair

from HealthDay News

A panel of expert advisors to the FDA recently voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status. The panel voted 11 to 4 against the sale of the popular medication without a doctor's approval, The Associated Press reported. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063